GentiBio
Director, Discovery Research
Jounce Therapeutics
Program Team Leader JTX-1811 (now GS-1811), Sr. Scientist, IO, Discovery
Celsius Therapeutics
Principal Scientist, Discovery
Jounce Therapeutics
Program Team Leader JTX-1811 (now GS-1811), Principal Scientist, IO
NovImmune
Preclinical Research, anti-TLR4 Program (NI-0101, now partnered with Genentech)
Harvard Medical School
Postdoctoral Research Fellow, Immunology Division, Treg cell Biology, (Mathis.D, Benoist.C lab)
Merrimack Pharmaceuticals
Sr. Scientist, IO, Discovery
NovImmune
Industrial PhD, Immunotherapy, T cell Program (NI-0401, FORALUMAB, now partnered with Tiziana)
Harvard Medical School
Université Pierre et Marie Curie (Paris VI)
University of Geneva
